Christopher A. Marlett, Director at Cue Biopharma, Inc. (CUE), sold 1,053,437 shares at $17.00 ($720K) on 2019-12-19, disclosed to the SEC on 2019-12-19.
Open-market sale of $720k CUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,007,973 | $0 | 0.0% |
| 2 | $15.73 | 20,732 | $326K | 45.3% |
| 3 | $15.73 | 20,732 | $326K | 45.3% |
| 4 | $17.00 | 4,000 | $68K | 9.4% |
| Total | $0.68 avg | 1,053,437 | $720K | 100% |
| Filing → |
| MDBH | BUY | 2025-10-07 | $14K | — | Filing → |
| MDBH | BUY | 2025-08-29 | $11K | — | Filing → |
| MDBH | BUY | 2025-08-27 | $13K | — | Filing → |